These drugs , copyright and Wegovy, represent a significant shift in how treating type 2 diabetes and, increasingly, obesity . They work as GLP-1 receptor agonists , mimicking the action of a inherent hormone https://opensocialfactory.com/story26453048/copyright-semaglutide-understanding-the-the-glp-1-movement